Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes
Bone marrow (BM) mesenchymal stem/stromal cells (MSCs) are vital in hematopoiesis. Whether BM-MSCs alter their characteristics in Myelodysplastic Syndromes (MDS) is still controversial. We characterized MSCs of de novo MDS patients in Sri Lanka who have not been reported previously in the literature...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/2016/8012716 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832560795727167488 |
|---|---|
| author | A. J. I. S. Rathnayake H. W. W. Goonasekera V. H. W. Dissanayake |
| author_facet | A. J. I. S. Rathnayake H. W. W. Goonasekera V. H. W. Dissanayake |
| author_sort | A. J. I. S. Rathnayake |
| collection | DOAJ |
| description | Bone marrow (BM) mesenchymal stem/stromal cells (MSCs) are vital in hematopoiesis. Whether BM-MSCs alter their characteristics in Myelodysplastic Syndromes (MDS) is still controversial. We characterized MSCs of de novo MDS patients in Sri Lanka who have not been reported previously in the literature. We also analyzed MSCs derived from different MDS subtypes. MSCs were culture-expanded, characterized by flow cytometry, and induced towards osteogenic and adipogenic differentiation. Growth properties were determined using growth curves and population doubling times. Karyotyping and FISH were performed on MSCs. Cell morphology, differentiation potential, and CD marker expression of MDS-MSCs of all subtypes were comparable to those of control-MSCs. No significant growth differences were observed between control MSCs and MDS-MSCs of all subtypes (p>0.05). 31% of MDS-MSCs had chromosomal aberrations (der(3),del(6q),del(7p), loss of chromosomes) whose BM karyotypes were normal. Highest percentage of karyotypic abnormalities was observed in RCMD-MSCs. Patients with abnormal BM karyotypes had no aberrant MSC clones. Results show that in spite of presence of genetically abnormal clones in MDS-MSC populations, in vitro phenotypic and growth characteristics of MSCs in MDS remain unchanged. Further, the occurrence of genetic abnormalities in BM-MSCs in MDS could be considered as an autonomous event from that of their hematopoietic counterparts. |
| format | Article |
| id | doaj-art-2c6b8bb4f64148be899e69c5b083a63b |
| institution | Kabale University |
| issn | 2210-7177 2210-7185 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Analytical Cellular Pathology |
| spelling | doaj-art-2c6b8bb4f64148be899e69c5b083a63b2025-02-03T01:26:43ZengWileyAnalytical Cellular Pathology2210-71772210-71852016-01-01201610.1155/2016/80127168012716Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic SyndromesA. J. I. S. Rathnayake0H. W. W. Goonasekera1V. H. W. Dissanayake2Human Genetics Unit, Faculty of Medicine, University of Colombo, 00800 Colombo, Sri LankaHuman Genetics Unit, Faculty of Medicine, University of Colombo, 00800 Colombo, Sri LankaHuman Genetics Unit, Faculty of Medicine, University of Colombo, 00800 Colombo, Sri LankaBone marrow (BM) mesenchymal stem/stromal cells (MSCs) are vital in hematopoiesis. Whether BM-MSCs alter their characteristics in Myelodysplastic Syndromes (MDS) is still controversial. We characterized MSCs of de novo MDS patients in Sri Lanka who have not been reported previously in the literature. We also analyzed MSCs derived from different MDS subtypes. MSCs were culture-expanded, characterized by flow cytometry, and induced towards osteogenic and adipogenic differentiation. Growth properties were determined using growth curves and population doubling times. Karyotyping and FISH were performed on MSCs. Cell morphology, differentiation potential, and CD marker expression of MDS-MSCs of all subtypes were comparable to those of control-MSCs. No significant growth differences were observed between control MSCs and MDS-MSCs of all subtypes (p>0.05). 31% of MDS-MSCs had chromosomal aberrations (der(3),del(6q),del(7p), loss of chromosomes) whose BM karyotypes were normal. Highest percentage of karyotypic abnormalities was observed in RCMD-MSCs. Patients with abnormal BM karyotypes had no aberrant MSC clones. Results show that in spite of presence of genetically abnormal clones in MDS-MSC populations, in vitro phenotypic and growth characteristics of MSCs in MDS remain unchanged. Further, the occurrence of genetic abnormalities in BM-MSCs in MDS could be considered as an autonomous event from that of their hematopoietic counterparts.http://dx.doi.org/10.1155/2016/8012716 |
| spellingShingle | A. J. I. S. Rathnayake H. W. W. Goonasekera V. H. W. Dissanayake Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes Analytical Cellular Pathology |
| title | Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes |
| title_full | Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes |
| title_fullStr | Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes |
| title_full_unstemmed | Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes |
| title_short | Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes |
| title_sort | phenotypic and cytogenetic characterization of mesenchymal stromal cells in de novo myelodysplastic syndromes |
| url | http://dx.doi.org/10.1155/2016/8012716 |
| work_keys_str_mv | AT ajisrathnayake phenotypicandcytogeneticcharacterizationofmesenchymalstromalcellsindenovomyelodysplasticsyndromes AT hwwgoonasekera phenotypicandcytogeneticcharacterizationofmesenchymalstromalcellsindenovomyelodysplasticsyndromes AT vhwdissanayake phenotypicandcytogeneticcharacterizationofmesenchymalstromalcellsindenovomyelodysplasticsyndromes |